TY - JOUR
T1 - Independent NF1 mutations underlie café-au-lait macule development in a woman with segmental NF1
AU - Freret, Morgan E.
AU - Anastasaki, Corina
AU - Gutmann, David H.
N1 - Funding Information:
M.E. Freret and C. Anastasaki report no disclosures. D.H. Gutmann holds patents for the identification of the ND1 gene and mTOR regulator; has received research support from the US Army Department of Defense, the Giorgio Foundation, the Children’s Tumor Foundation, and the Neurofibromatosis Acceleration Therapeutics Program; receives license fee payments for the TSC1 knockout mouse; and receives royalty payments for the NF1 gene patent. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/NG.
Funding Information:
The Article Processing Charge was funded by NIH.
Funding Information:
This work was supported by the NIH (1-R35-NS07211-01, D.H. Gutmann).
Publisher Copyright:
© 2018 American Academy of Neurology.
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Segmental neurofibromatosis type 1 (NF1) is an under-recognized form of NF1 caused by postzygotic somatic loss-of-function NF1 gene mutations that affect a subset of cells in the body. 1 This is in contrast to classic or generalized NF1, in which a germline NF1 gene mutation affects all diploid cells in the body. In the segmental NF1 variant, individuals typically exhibit clinical features characteristic of generalized NF1, such as café-au-lait macules (CALMs), skinfold freckling, and neurofibromas, restricted to one segment of the body. For this reason, establishing the diagnosis can be challenging because the underlying NF1 gene mutation is often not detected in the blood. Underscoring the challenges of caring for individuals with this variant of NF1, we describe a woman with segmental NF1 referred to us at 22 years of age for evaluation.
AB - Segmental neurofibromatosis type 1 (NF1) is an under-recognized form of NF1 caused by postzygotic somatic loss-of-function NF1 gene mutations that affect a subset of cells in the body. 1 This is in contrast to classic or generalized NF1, in which a germline NF1 gene mutation affects all diploid cells in the body. In the segmental NF1 variant, individuals typically exhibit clinical features characteristic of generalized NF1, such as café-au-lait macules (CALMs), skinfold freckling, and neurofibromas, restricted to one segment of the body. For this reason, establishing the diagnosis can be challenging because the underlying NF1 gene mutation is often not detected in the blood. Underscoring the challenges of caring for individuals with this variant of NF1, we describe a woman with segmental NF1 referred to us at 22 years of age for evaluation.
UR - http://www.scopus.com/inward/record.url?scp=85060826274&partnerID=8YFLogxK
U2 - 10.1212/NXG.0000000000000261
DO - 10.1212/NXG.0000000000000261
M3 - Article
C2 - 30065955
AN - SCOPUS:85060826274
SN - 2376-7839
VL - 4
JO - Neurology: Genetics
JF - Neurology: Genetics
IS - 4
M1 - e261
ER -